Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - European Market Recap: FTSE 100 (0.14%) to 10363.93, DAX closed, CAC40 closed, STOXX 600 closed

May 01 ,2026

  • Synopsis:

    • European equity markets that were open, namely UK and Denmark, ended the session mixed. The majority of European markets were closed for Labor Day holidays.

    • Activity light in Europe due to holidays. Investors evaluating yesterday's policy decisions from ECB and BOE. Both kept policy settings unchanged. Comments from President Lagarde and ECB sources reinforce expectations for June rate hike. BOE policy outlook more uncertain.

    • Middle East headlines remain in focus as Israel intensifies Lebanon attacks and Iran reportedly sends a new set of proposals to the United States through mediator Pakistan

    • Denmark +0.7%, FTSE 100 (0.1%) having spent the session slightly lower on the day, and FTSE 250 +0.3%

    • UK and Ireland markets will be closed on Mon for Early May bank holiday

    • Economic data included two data points underlying the resilience of the housing market on the UK, better than expected Mar mortgage approvals, whilst Nationwide commented, UK annual house price growth picked up in Apr despite the uncertainty caused by developments in the Middle East. The UK economy and housing market have proved remarkably resilient in recent years. This provides some confidence that, if the latest shock passes relatively quickly, and energy prices normalise in the quarters ahead, any near-term softening in the housing market will also prove short lived.

    • M&A news flow included Banco de Sabadell (SAB.SM) confirming completes sale of TSB Banking Group to Santander UK (SAN.SM), to distribute an extraordinary cash dividend. Consob approves Banca CF+'s offer document in connection with the acquisition of the remaining shares of Banca Sistema (BST.IM). UCB (UCB.BB) announces acquisition of IMIDomics' Patient Insight Business. Next Geosolutions Europe (NXT.IM) acquires a further 7.1% of Rana Subsea, bringing its total stake to 82.5%. Gyldendal (GYLD.A.DC) completes acquisition of 80% of the shares in the Swedish publishing group Tukan and confirms FY outlook. Reportedly, bp (BP.LN) considering potentially exiting part or all of its operations in the UK North Sea.

    • Amongst the handful of company earnings/updates were Pearson (PSON.LN) and NatWest Group (NWG.LN) and Schouw & Co (SCHO.DC)

    • Sovereign credit rating reviews due after the close include Fitch (Ireland).

  • Digest:

    • Macro/Peripheral markets:

      • ECB:

        • ECB officials see June rate hike if energy prices do not ease first -Reuters, Bloomberg

      • Germany:

        • Greens and CDU in the southwest agree on coalition - Handelsblatt

      • Greece:

        • 24-hour strike, called by the country's main unions, sees thousands strike across Greece - ekathimerini

      • Ireland:

        • Nominations period for the Dublin Central and Galway West bye-elections has closed; bye-elections will take place on 22-May - RTE

      • UK:

        • BOE chief economist Pill says MPC wants to retain optionality - wires

        • Tony Blair institute calls for end to 'unaffordable' triple lock - London Times

        • Who are Starmer's potential challengers? - Guardian

        • Parties' prospects examined in next week elections - Economics Observatory

        • The Green Party of England and Wales is calling for a £15/hour minimum wage for all workers by Apr- 27 - BBC

      • Ukraine:

        • Zelensky's push for EU membership strains ties with allies - FT

    • Company news:

      • Notable Gainers

        • +9.8% GLE.LN (MJ Gleeson) -- expects adj. Group profit before tax for year ending 30-Jun-26 will be in line with market consensus

        • +9.6% HUSCO.DC (HusCompagniet) -- Q1 EBITDA DKK18M vs FactSet DKK6.5M [3 est, DKK2-9.4M]; reaffirms FY guidance

        • +5.7% AOJ.B.DC (Brødrene A & O Johansen) -- Q1 pretax income DKK53.8M vs FactSet DKK43M, reaffirms FY guidance

        • +4.1% SCHO.DC (Schouw & Co)

          • Q1 net income attributable DKK165M vs FactSet DKK206M [1 est]; reaffirms FY guidance

          • BioMar (+BIOMAR.DC) announces intention to IPO on Nasdaq Copenhagen

        • +3.4% PSON.LN (Pearson) -- Q1 underlying sales +4%; on track to deliver FY26 guidance

        • +2.7% ROR.LN (Rotork) -- Q1performance was in line with management expectations; 2026 outlook is unchanged

        • +2.5% HFD.LN (Halfords Group) -- upgraded to buy from hold at Canaccord Genuity

        • +2.1% SRB.LN (Serabi Gold) -- FY EPS $0.71 vs year-ago $0.25; Confirms FY production outlook

        • +2.0% HAS.LN (Hays) downgraded to neutral from buy at Citi

        • +1.5% RCN.LN (Redcentric) -- completes sale of Redcentric Data Centre to Stellanor Datacenters Group

        • +1.3% ACSO.LN (accesso Technology Group) -- CEO Steve Brown steps down

        • +1.3% NRR.LN (NewRiver REIT) -- FY26 Underlying FFO/share and EPRA NTA/share expected to be in-line with analyst consensus

        • +1.2% GFTU.LN (Grafton Group) -- completes acquisition of Mercaluz

        • +0.7% DGE.LN (Diageo)

          • Trump says will be removing certain tariffs and restrictions on Whiskey -- Truth Social post

          • Launches strategic push into "ready-to-drink" beverages category - FT

        • +0.6% MCB.LN (McBride) -- commences the second tranche of its share buyback program

      • Notable Decliners

        • -13.2% PRO.LN (ProService Building Services Marketplace( -- FY trading update: adjusted EBITDA for the period is expected to be at breakeven

        • -13.1% STX.LN (Shield Therapeutics) -- Q1 EBIT $2.5M vs year-ago ($4.4M); CFO Santosh Shanbhag to step down

        • -3.1% NWG.LN (NatWest Group) -- Q1 net income £1.51B vs consensus £1.34B; expects FY income ex-items to be at top end of previously guided range

        • -2.9% AZN.LN (AstraZeneca)

          • FDA ODAC recommends Truqap in prostate cancer

          • issues press release on FDA ODAC panel's vote supporting TRUQAP sNDA in prostate cancer

          • FDA Oncologic Drugs Advisory Committee (ODAC) did not reach a majority vote in favor of the benefit risk profile of AstraZeneca's camizestrant in combination with a cyclin-dependent kinase (CDK) 4/6 inhibitor

          • FDA ODAC panel votes 7-1-1 to support AstraZeneca's TRUQAP sNDA in prostate cancer

        • -2.6% FLS.DC (FLSmidth & Co.) -- investigates potential non-compliance with sanctions regulations and takes steps to enhance compliance measures

        • -2.4% UU.LN (United Utilities Group) -- downgraded to neutral from buy at Citi

        • -2.2% SVT.LN (Severn Trent) -- downgraded to neutral from buy at Citi

        • -1.5% GSK.LN (GSK) -- UK MHRA approves Lynavoy (linerixibat) for itch in adults with PBC

        • -1.3% PULS.LN (Pulsar Group) -- FY EPS (7.8p) and unclear if comparable to FactSet 2.2p [1 est]

        • -1.1% PAGE.LN (PageGroup) -- downgraded to neutral from buy at Citi

        • -0.9% KAP.LN (Kazatomprom) -- initiated hold at Freedom Broker

        • -0.2% ORSTED.DC (Ørsted) -- completes divestment of European onshore business to CIP

      • Markets that were closed today

        • BIRG.ID (Bank of Ireland Group) -- total income in Q1 tracking in line with expectations; guides FY26

        • AALB.NA (Aalberts) -- Q1 EBITA €109.7M vs FactSet €104.0M; expect improvements on organic revenue growth and EBITA margin in 2026

        • ATTICA.GA (Attica Holdings) -- FY EBITDA €85.4M, (11%) vs year-ago €96.3M

        • PNOR.NO (PetroNor E&P) -- provides update on the previously announced oil sales lifting

        • Broker recommendation changes

          • Upgrades:

            • REP.SM (Repsol) -- buy from neutral at Goldman Sachs

            • ELK.NO (Elkem) -- buy from hold at SEB

          • Downgrades:

            • AIXA.GR (Aixtron) -- equal weight from overweight at Barclays

            • TE.FP (Technip Energies) -- neutral from buy at Goldman Sachs

            • AKSO.NO (Aker Solutions) -- hold from buy at Pareto

            • ADEN.SW (Adecco Group) -- neutral from buy at Citi

            • RAND.SW (Randstad) -- neutral from buy at Citi

            • TE.FP (Technip Energies) -- neutral from buy at Goldman Sachs

    • EU companies reporting Monday:

      • Earnings:

        • DACHs: DMG MORI (GIL.GR), Stabilus (STM.GR)

        • Nordics: HEXPOL (HPOL.B.SS), Ratos (RATO.B.SS), Fagerhult Group (FAG.SS), Ilkka (ILKKA.FH)

      • Trading Update: France: Elis (ELIS.FP), Vicat (VCT.FP), Bilendi (ALBLD.FP)

      • Sales/Output: Moscow Exchange MICEX-RTS (MOEX.RU)

      • CMD/Events: STMicroelectronics (STMPA.FP) The LEO Opportunity at 15:30CET (webcast link), Unicredit (UCG.IM) EGM regarding the planned takeover bid for Commerzbank (CBK.GR)

  • Data:

    • Economics:

      • Netherlands Mar retail sales +2.9% y/y vs consensus +1.8%, prior revised +1.5% from +1.3%

      • Switzerland Mar retail sales +0.5% y/y vs consensus +1.0%, prior revised +0.4% from +0.9%

      • UK

        • Apr house price index +3.0% y/y vs consensus +2.2%, prior +2.2% - Nationwide

        • Apr manufacturing PMI 53.7 vs preliminary 53.6

        • Mar mortgage approvals 63.53K vs consensus 60.0K, prior revised 62.71K from 62.58K

        • Mar M4 money supply +0.8% m/m vs consensus +0.5%, prior revised +0.7% from +0.6%

    • Markets:

      • WTI Crude (Jun 26): ($3.21) or (3.06%) to $101.86

      • €-$ +0.0032 or +0.27% to 1.1764

      • £-$ +0.0019 or +0.14% to 1.3624

      • €-£ +0.0010 to 0.8634

      • S&P 500 +0.68

      • Performance year-to-date:

        • FTSE 100: +4.36%

        • DAX: (0.81%)

        • CAC: (0.43%)

        • MIB: +7.35%

        • Stoxx 600: +3.22%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.